# Elroselabs Inc. – FDA Inspection, Dec 21, 2017

Source: https://www.keypedia.com/records/fda_inspections/elroselabs-inc/d4158f03-ef76-44c5-a451-3555513aa1d7
Source feed: FDA_Inspections

> FDA inspection 1035796 of Elroselabs Inc., December 21, 2017. Classification: Official Action Indicated (OAI). 15 citations under 21 CFR part 211. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1035796
- Company Name: Elroselabs Inc.
- Inspection Date: 2017-12-21
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 15

## Related Officers

- [Christos G. Tsingelis](https://www.keypedia.com/people/christos-g-tsingelis/a0bacf2c-cf1f-4c34-996a-fcc1aa371610)
- [Issuing Officer](https://www.keypedia.com/people/hala-l-selby/4b507d3e-3d23-4c0c-97d4-495a25dc3947)

Company: https://www.keypedia.com/companies/elroselabs-inc/dfb02e0d-ab91-4e67-ae37-27feadc48931

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c